The Psorcast Study: A Validation Study of a Smartphone Sensor-Based Patient-Driven Detection of Psoriatic Disease
Brief description of study
Smartphone-based and physician-assessed measures will be collected at baseline and 12 weeks after initiating a new therapy for psoriatic disease. Weekly digital assessments will also be performed.
Clinical Study Identifier: s23-00148
Principal Investigator:
Rebecca Haberman.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.